MedPath

PENBRITIN-250 PWS IM/IV 250MG/VIAL

PENBRITIN-250 PWS IM/IV 250MG/VIAL

Discontinued
DIN Number

02043157

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

wyeth-ayerst canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02043157
AIG Number0105873001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01CA01 AMPICILLIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular ,  Intravenous
AHFS Classification08:12.16.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

AMPICILLIN SODIUMActive
Strength: 250 MG / VIAL
Monograph: AMPICILLIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.